Epidemiological characterization of P. aeruginosa isolates of intensive care units in Egypt and Saudi Arabia;Caractérisation épidémiologique d'isolats de pseudomonas aeruginosa dans des unités de soins intensifs en Arabie Saoudite et en Égypte

Eastern Mediterranean Health Journal

Volumn 19, Issue 1, 2013, Pages 71-80

  Mansour, S A ^a   Eldaly, O ^a   Jiman Fatani, A ^b   Mohamed, M L ^a   Ibrahim, E M ^a  

^a ZAGAZIG UNIVERSITY   (Egypt)

^b KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AZTREONAM; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; GENTAMICIN; IMIPENEM; MEROPENEM; PIPERACILLIN; TOBRAMYCIN;

ADOLESCENT; ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; CHILD; CONTROLLED STUDY; DISK DIFFUSION; DNA EXTRACTION; EGYPT; ENTEROBACTERIAL REPETITIVE INTERGENIC CONSENSUS POLYMERASE CHAIN REACTION; EPIDEMIOLOGICAL DATA; FEMALE; HOSPITALIZATION; HUMAN; INFECTION; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; METALLO BETA LACTAMASES PRODUCING IMIPENEM RESISTANT PSEUDOMONAS AERUGINOSA; NONHUMAN; POLYMERASE CHAIN REACTION; PSEUDOMONAS AERUGINOSA; RISK FACTOR; SAUDI ARABIA; SCHOOL CHILD; YOUNG ADULT;

EID: 84927559813     PISSN: 10203397     EISSN: None     Source Type: Journal    
DOI: 10.26719/2013.19.1.71     Document Type: Article

References (43)

1. Driscoll JA, Brody SL, Kollef MH. The epidemiology, pathogenesis and treatment of Pseudomonas aeruginosa infections. Drugs, 2007, 67:351-368.
2. Hidron AI et al. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infection Control and Hospital Epidemiology, 2008, 29:996-1011.
3. Livermore DM. Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? Clinical Infectious Diseases, 2002, 34:634-640.
4. Cornaglia G, Giamarellou H, Rossolini GM. Metallo-β- lactamases: a last frontier for beta-lactams? Lancet Infectious Diseases, 2011, 11:381-393.
5. Cuttelod M et al. Molecular epidemiology of Pseudomonas aeruginosa in intensive care units over a 10-year period (1998- 2007). Clinical Microbiology and Infection, 2011, 17:57-62.
6. Pitt TL. Epidemiological typing of Pseudomonas aeruginosa. European Journal of Clinical Microbiology and Infectious Diseases, 1988, 7:238-247.
7. Olive DM, Bean P. Principles and applications of methods for DNA-based typing of microbial organisms. Journal of Clinical Microbiology, 1999, 37:1661-1669.
8. Douglas MW et al. Multi-drug resistant Pseudomonas aeruginosa outbreak in a burns unit--an infection control study. Burns, 2001, 27:131-135.
9. Talon D et al. Discriminatory power and usefulness of pulsed field gel electrophoresis in epidemiological studies of Pseudomonas aeruginosa. Journal of Hospital Infection, 1996, 32:135-145.
10. Kersulyte D et al. Comparison of arbitrarily primed PCR and macrorestriction (pulsed-field gel electrophoresis) typing of Pseudomonas aeruginosa strains from cystic fibrosis patients. Journal of Clinical Microbiology, 1995, 33:2216-2219.
11. Syrmis MW et al. Rapid genotyping of Pseudomonas aeruginosa isolates harboured by adult and paediatric patients with cystic fibrosis using repetitive-element-based PCR assays. Journal of Medical Microbiology, 2004, 53:1089-1096.
12. Sharples GJ, Lloyd RG. A novel repeated DNA sequence located in the intergenic regions of bacterial chromosomes. Nucleic Acids Research, 1990, 18:6503-6508.
13. de Bruijn FJ. Use of repetitive (Repetitive Extragenic Palindromic and Enterobacterial Repetitive Intergeneric Consensus) sequences and the polymerase chain reaction to fingerprint the genomes of Rhizobium meliloti isolates and other soil bacteria. Applied and Environmental Microbiology, 1992, 58:2180-2187.
14. Doebbeling BN et al. Removal of noscomial pathogens from the contaminated glove, Implications for glove reuse and hand washing. Annals of Internal Medicine, 1998, 109:394-398.
15. Govan JR. Studies on the pyocins of Pseudomonas aeruginosa: morphology and mode of action of contractile pyocins. Journal of General Microbiology, 1974, 80:1-15.
16. Cheesbrough M. Antimicrobial susceptibility testing. In: District laboratory practice in tropical countries. Part 2. Cambridge, UK, Cambridge University Press, 2006:132-143.
17. Collee JG, Miles RS, Watt B. Tests for the identification of bacteria. In: Collee JG et al., eds. Mackie and McCartney practical medical microbiology. New York, Churchill Livingstone, 1996:131-149.
18. Govan JRW. Pseudomonas, Stenotrophomonas, Burkholderia. In: Collee JG et al., eds. Mackie and McCartney practical medical microbiology. New York, Churchill Livingstone, 1996:413-424.
19. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial disk susceptibility tests; approved standard, 10th ed. Wayne, Pennsylvania, Clinical and Laboratory Standards Institute, 2009 (CLSI document M02-A10).
20. Yong D et al. Imipenem-EDTA disk method for differentiation of metallo beta lactamase-producing clinical isolates of Pseudomonas spp. and Acinetobacter spp. Journal of Clinical Microbiology, 2000, 240:3798-3801.
21. Pinna A et al. An outbreak of post-cataract surgery endophthalmitis caused by Pseudomonas aeruginosa. Ophthalmology, 2009, 116(12):2321-6e1-4.
22. Versalovic J, Koeuth T, Lupski JR. Distribution of repetitive DNA sequences in eubacteria and application to fingerprinting of bacterial genomes. Nucleic Acids Research, 1991, 19:6823-6831.
23. Viljoen GJ, Nel LH, Crowther JR. Molecular diagnostic PCR handbook. Dordrecht, Netherlands, Springer, 2005.
24. Hunter PR. Reproducibility and indices of discriminatory power of microbial typing methods. Journal of Clinical Microbiology, 1990, 28:1903-1905.
25. Ashour MS et al. Extended spectrum beta-lactamases mediating resistance to extended spectrum beta-lactam antibiotics among Gram-negative bacteria in Cairo. Egyptian Journal of Medical Microbiology, 2003, 12:193-200.
26. Gad GF et al. Characterization of Pseudomonas aeruginosa isolated from clinical and environmental samples in Minia, Egypt: prevalence, antibiogram and resistance mechanisms. Journal of Antimicrobial Chemotherapy, 2007, 60:1010-1017.
27. Al Johani SM et al. Prevalence of antimicrobial resistance among gram-negative isolates in an adult intensive care unit at a tertiary care center in Saudi Arabia. Annals of Saudi Medicine, 2010, 30:364-369.
28. Weber DJ, Raasch R, Rutala WA. Nosocomial infections in the ICU: the growing importance of antibiotic-resistant pathogens. Chest, 1999, 115:34S-41S.
29. Ruiz CM, Guerrero PJ, Romero PC. tiologia de la neumonia asociada a ventilacion mecanica en un hospital clinico. Asociacion con co-morbilidad, uso previo de antimicrobianos y mortalidad. [Etiology of ventilator-associated pneumonia in a university hospital. Association with comorbidity, previous use of antibiotics and mortality.] Revista Chilena de Infectología, 2007, 24:131-136.
30. Zavascki AP, Cruz RP, Goldani LZ. Risk factors for imipenemresistant Pseudomonas aeruginosa: a comparative analysis of two case-control studies in hospitalized patients. Journal of Hospital Infection, 2005, 59:96-101.
31. Crivaro A et al. Pseudomonas aeruginosa in a neonatal intensive care unit: molecular epidemiology and infection control measures. Infection Control and Hospital Epidemiology, 2009, 35:1083-1089.
32. Kamel GM et al. Susceptibility pattern of Pseudomonas aeruginosa against antimicrobial agents and some plant extracts with focus on its prevalence in different sources. Global Veterinaria, 2011, 6:61-72.
33. Fatma AA et al. Imipenem resistance and BLAIMP gene among hospital strains of Pseudomonas aeruginosa at university hospital in Egypt. Journal of Infection in Developing Countries, 2007, 1:42-47.
34. Al-Agamy MH et al. High prevalence of metallo-beta-lactamase- producing Pseudomonas aeruginosa from Saudi Arabia. Journal of Chemotherapy (Florence, Italy), 2009, 21:461-462.
35. El-Teheawy MM et al. The pattern of antimicrobial use in general hospitals in Egypt. Chemiotherapia, 1998, 7:387-392.
36. Hocquet D et al. Genetic and phenotypic variations of a resistant Pseudomonas aeruginosa epidemic clone. Antimicrobial Agents and Chemotherapy, 2003, 47:1887-1894.
37. Pellegrino FLPC et al. Occurrence of amultidrug-resistant Pseudomonas aeruginosa clone in different hospitals in Rio de Janeiro, Brasil. Journal of Clinical Microbiology, 2002, 40:2420-2424.
38. Trautmann M, Lepper PM, Haller M. Ecology of Pseudomonas aeruginosa in the intensive care unit and the evolving role of water outlets as a reservoir of the organism. American Journal of Infection Control, 2005, 33(5 Suppl.):S41-S49.
39. Freitas AL, Barth AL. Typing of Pseudomonas aeruginosa from hospitalised patients. Comparison of susceptibility and biochemical profiles with genotypes. Brazilian Journal of Medical and Biological Research, 2004, 37:77-82.
40. Foca M et al. Endemic Pseudomonas aeruginosa infection in a neonatal intensive care unit. New England Journal of Medicine, 2000, 343:695-700.
41. Yorioka K, Oie S, Kamiya A. Microbial contamination of suction tubes attached to suction instruments and preventive methods. Japanese Journal of Infectious Diseases, 2010, 63:124-127.
42. Poirel L et al. Characterization of class 1 integrons from Pseudomonas aeruginosa that contain the blaVIM-2 carbapenem- hydrolyzing beta-lactamase gene and of two novel aminoglycoside resistance gene cassettes. Antimicrobial Agents and Chemotherapy, 2001, 45:546-552.
43. Rossolini GM. Acquired metallo-beta-lactamases: an increasing clinical threat. Clinical Infectious Diseases, 2005, 41:1557-1558.